Miniaturized biological systems capable of mimicking complex organ architecture are transforming regenerative medicine. Organoids and lab-grown organs offer powerful platforms for modeling disease, studying development, and exploring therapeutic interventions without relying on animal models. Derived from stem cells and grown in three-dimensional culture systems, organoids self-organize into structures resembling the functional units of organs like the liver, intestine, brain, or kidneys. Coupled with bioreactors and advanced scaffolds, lab-grown organs are progressing toward clinical relevance, especially in transplantation and toxicity testing. Organoids and lab-grown organs bridge developmental biology with engineering, opening new frontiers for personalized treatment, functional organ replacement, and ethical drug discovery that mirrors in vivo responses with remarkable fidelity.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : AI-integrated high-throughput tissue-chip for brain aging
Kunal Mitra, Florida Tech, United States
Title : Assembly and stability of on-chip microvasculature
Kara E McCloskey, University of California, Merced, United States